These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 17243064

  • 1. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
    Sheng WH, Hung CC, Wu RJ, Wang JT, Chen PJ, Chang SC, Kao JH.
    Clin Infect Dis; 2007 Feb 15; 44(4):584-90. PubMed ID: 17243064
    [Abstract] [Full Text] [Related]

  • 2. Characterization of GBV-C infection in HIV-1 infected patients.
    Canducci F, Uberti Foppa C, Boeri E, Racca S, Gallotta G, Grasso MA, Calori G, Lazzarin A, Clementi M.
    J Biol Regul Homeost Agents; 2003 Feb 15; 17(2):191-4. PubMed ID: 14518722
    [Abstract] [Full Text] [Related]

  • 3. Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, Morsica G, Pizzaferri P, Ladisa N, Sighinolfi L, Chiodera A, Solmone M, Lalle E, Ippolito G, Monforte Ad, HepaICoNA Study Group, ICoNA Study Group.
    Antivir Ther; 2005 Feb 15; 10(1):109-17. PubMed ID: 15751768
    [Abstract] [Full Text] [Related]

  • 4. Effect of GB virus C co-infection on response to generic HAART in African patients with HIV-1 clade C infection.
    Mosam A, Sathar MA, Dawood H, Cassol E, Esterhuizen TM, Coovadia HM.
    AIDS; 2007 Jun 19; 21(10):1377-9. PubMed ID: 17545721
    [Abstract] [Full Text] [Related]

  • 5. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
    Sheng WH, Hung CC, Kao JH, Chang SY, Chen MY, Hsieh SM, Chen PJ, Chang SC.
    Clin Infect Dis; 2007 Apr 01; 44(7):988-95. PubMed ID: 17342655
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of GB virus type C in urban Americans infected with human immunodeficiency virus type 1.
    Smith SM, Donio MJ, Singh M, Fallon JP, Jitendranath L, Chkrebtii N, Slim J, Finkel D, Perez G.
    Retrovirology; 2005 May 31; 2():38. PubMed ID: 15927079
    [Abstract] [Full Text] [Related]

  • 7. Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians.
    Souza IE, Zhang W, Diaz RS, Chaloner K, Klinzman D, Stapleton JT.
    HIV Med; 2006 Jan 31; 7(1):25-31. PubMed ID: 16313289
    [Abstract] [Full Text] [Related]

  • 8. Infection with GB virus C and reduced mortality among HIV-infected patients.
    Tillmann HL, Heiken H, Knapik-Botor A, Heringlake S, Ockenga J, Wilber JC, Goergen B, Detmer J, McMorrow M, Stoll M, Schmidt RE, Manns MP.
    N Engl J Med; 2001 Sep 06; 345(10):715-24. PubMed ID: 11547740
    [Abstract] [Full Text] [Related]

  • 9. Prevalence and distribution of the GBV-C/HGV among HIV-1-infected patients under anti-retroviral therapy.
    Alcalde R, Nishiya A, Casseb J, Inocêncio L, Fonseca LA, Duarte AJ.
    Virus Res; 2010 Aug 06; 151(2):148-52. PubMed ID: 20420864
    [Abstract] [Full Text] [Related]

  • 10. GB virus C and HIV-1 RNA load in single virus and co-infected West African individuals.
    Li C, Collini P, Danso K, Owusu-Ofori S, Dompreh A, Candotti D, Opare-Sem O, Allain JP.
    AIDS; 2006 Feb 14; 20(3):379-86. PubMed ID: 16439871
    [Abstract] [Full Text] [Related]

  • 11. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD, HepaI.Co.N.A. Study Group, Italian Cohort Naive for Antiretrovirals Study Group.
    Clin Infect Dis; 2005 Jun 15; 40(12):e101-9. PubMed ID: 15909251
    [Abstract] [Full Text] [Related]

  • 12. Persistent GB virus C infection and survival in HIV-infected men.
    Williams CF, Klinzman D, Yamashita TE, Xiang J, Polgreen PM, Rinaldo C, Liu C, Phair J, Margolick JB, Zdunek D, Hess G, Stapleton JT.
    N Engl J Med; 2004 Mar 04; 350(10):981-90. PubMed ID: 14999110
    [Abstract] [Full Text] [Related]

  • 13. GBV-C viremia and clinical events in advanced HIV infection.
    Sahni H, Kirkwood K, Kyriakides TC, Stapleton J, Brown ST, Holodniy M, OPTIMA Study Team.
    J Med Virol; 2014 Mar 04; 86(3):426-32. PubMed ID: 24249700
    [Abstract] [Full Text] [Related]

  • 14. Influence of hepatitis G virus (GB virus C) on the prognosis of HIV-infected women.
    Campos AF, Tengan FM, Silva SA, Levi JE.
    Int J STD AIDS; 2011 Apr 04; 22(4):209-13. PubMed ID: 21515753
    [Abstract] [Full Text] [Related]

  • 15. Enhanced and resumed GB virus C replication in HIV-1-infected individuals receiving HAART.
    Björkman P, Flamholc L, Molnegren V, Marshall A, Güner N, Widell A.
    AIDS; 2007 Jul 31; 21(12):1641-3. PubMed ID: 17630561
    [Abstract] [Full Text] [Related]

  • 16. Frequency and genotype of GB virus C among Iranian patients infected with HIV.
    Hekmat S, Mohraz M, Vahabpour R, Jam S, Bahramali G, Banifazl M, Aghakhani A, Eslamifar A, Mahboudi F, Edalat R, Ramezani A.
    J Med Virol; 2008 Nov 31; 80(11):1941-6. PubMed ID: 18814233
    [Abstract] [Full Text] [Related]

  • 17. GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study.
    Van der Bij AK, Kloosterboer N, Prins M, Boeser-Nunnink B, Geskus RB, Lange JM, Coutinho RA, Schuitemaker H.
    J Infect Dis; 2005 Mar 01; 191(5):678-85. PubMed ID: 15688280
    [Abstract] [Full Text] [Related]

  • 18. Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis.
    Zhang W, Chaloner K, Tillmann HL, Williams CF, Stapleton JT.
    HIV Med; 2006 Apr 01; 7(3):173-80. PubMed ID: 16494631
    [Abstract] [Full Text] [Related]

  • 19. Effect of GB virus C coinfection on response to antiretroviral treatment in human immunodeficiency virus-infected patients.
    Rodriguez B, Woolley I, Lederman MM, Zdunek D, Hess G, Valdez H.
    J Infect Dis; 2003 Feb 01; 187(3):504-7. PubMed ID: 12552436
    [Abstract] [Full Text] [Related]

  • 20. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL.
    APMIS Suppl; 2003 Feb 01; (114):1-37. PubMed ID: 14626050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.